Cofertility
Series A in 2025
Cofertility is a fertility service provider that focuses on creating a human-centered ecosystem to support individuals and families throughout their fertility journeys. The company offers a range of services, including egg donation and egg-freezing, facilitating third-party reproduction. Cofertility's platform connects candidates with suitable egg donors and allows women to freeze their eggs at no cost by donating half of their eggs to another family. This innovative approach aims to enhance access to fertility care and promote family building, addressing the needs of various users in the fertility landscape.
Ignota Labs
Seed Round in 2025
Ignota Labs is a pioneering medical technology company focused on enhancing the drug discovery process through advanced artificial intelligence methods. By utilizing deep learning and machine learning algorithms, the company aims to analyze complex molecular data to predict toxicity early in the development of pharmaceuticals. This proactive approach helps to identify harmful compounds, thereby minimizing environmental impact and waste. Ignota Labs' innovative platform not only streamlines the drug discovery process but also enhances drug safety, ultimately facilitating the timely introduction of life-changing medications to the market.
Afynia Laboratories
Seed Round in 2025
Aima Laboratories is a women's health healthcare company that provides innovative solutions to diagnostic and therapeutic difficulties. AIMA is working on the first non-invasive endometriosis diagnostic tool for the market. If you have chronic pelvic/period pain or are having difficulty becoming pregnant, you may have endometriosis.
Qnovia is a biotechnology company that specializes in aerosol science and drug delivery systems. It focuses on developing innovative inhalation-based technologies that enhance the delivery of a wide range of pharmaceuticals, addressing the limitations of traditional drug delivery methods. The company aims to improve patient outcomes by creating efficient aerosol devices and formulations that safely administer medications and nicotine. Qnovia is committed to advancing public health through responsible innovation, transparent product information, and effective oversight, positioning itself at the forefront of the medical device industry. Its platform not only optimizes the user experience but also facilitates access to new inhaled therapies, ultimately contributing to better health management for patients.
Arda Therapeutics
Series A in 2024
Arda Therapeutics is a biotechnology company focused on addressing chronic diseases and the effects of aging by targeting and eliminating pathogenic cells responsible for these conditions. Established in 2021 in the San Francisco Bay Area, the company utilizes single-cell data from patients to identify specific pathogenic cells and their markers. This precise identification allows Arda to develop therapies that aim to eradicate only those detrimental cells, thereby addressing the root causes of diseases while preserving healthy cells. By removing entire pathological networks, Arda Therapeutics strives to offer effective treatments that can lead to potential cures for patients suffering from chronic illnesses.
Afynia Laboratories
Seed Round in 2024
Aima Laboratories is a women's health healthcare company that provides innovative solutions to diagnostic and therapeutic difficulties. AIMA is working on the first non-invasive endometriosis diagnostic tool for the market. If you have chronic pelvic/period pain or are having difficulty becoming pregnant, you may have endometriosis.
Grayce, Inc. is a health care agency based in San Francisco that specializes in providing personalized guidance and support for families caring for aging adults and children. Founded in 2019, the company offers a range of services designed to assist caregivers with various aspects of care, including insurance, finances, legal plans, medical care, home care, housing, daily needs, and overall well-being. Each member of Grayce receives dedicated support from a social worker who helps manage their comprehensive care needs by planning, prioritizing, identifying resources, coordinating care, and advocating on their behalf. Through its social care management platform, Grayce empowers family caregivers to navigate the complexities of caring for vulnerable loved ones.
OverT Bio
Seed Round in 2024
OverT Bio is a biotechnology company focused on developing cell therapies for cancer treatment. The company specializes in identifying and creating novel genetic modifications that empower immune cells to navigate and overcome the obstacles posed by tumors. Through its innovative approach, OverT Bio aims to enhance the effectiveness and durability of immunotherapies, contributing to advancements in cancer identification and treatment within the healthcare sector.
Testmate Health
Seed Round in 2024
Testmate Health is a medtech startup and an award-winning spin-off from the University of Geneva, Switzerland. The company has developed a smartphone-compatible platform that offers a test kit capable of diagnosing diseases with identifiable DNA or RNA sequences without laboratory involvement, providing rapid results at home in minutes. Their initial product is a user-friendly, all-in-one kit that serves as the first rapid urine self-test for the four most common sexually transmitted diseases (STDs). Given that one million new STDs are diagnosed daily, Testmate Health addresses a critical gap in the market, as traditional testing often requires lab processing and can take up to a week for results. The kit not only delivers immediate results but also allows users to scan their results with a smartphone, facilitating quick access to treatment if necessary. Additionally, Testmate Health has plans to expand its offerings with test kits for other diseases, empowering individuals to manage their health conveniently from home.
Limbic is a London-based company founded in 2017 that specializes in developing innovative solutions for mental healthcare. The company creates an AI-enabled platform and software development kit (SDK) that measures heart rates through wearable devices, such as the Apple Watch, to assess users' emotional states. By leveraging machine learning, Limbic aims to enhance psychological therapy by providing insights into patients' mental health conditions. Additionally, the company offers medical devices that facilitate referrals and clinical assessments, thereby supporting mental health professionals in delivering effective therapies. Limbic is committed to addressing the growing mental health crisis by providing scalable solutions that improve the well-being of individuals.
Ezra AI, Inc. is a company focused on developing artificial intelligence technology to enhance cancer detection through investigational devices. Established in 2017 and headquartered in New York, it has pioneered a novel approach to cancer screening utilizing full-body MRI technology supported by AI. The company's initial product is an FDA-cleared software designed to assist radiologists in interpreting MRI images specifically for prostate cancer. Ezra AI primarily serves customers in New York and California, aiming to improve early cancer detection and diagnosis through its innovative solutions.
Hone Health
Venture Round in 2024
Hone Health is a men's health platform that provides personalized care through data-driven insights and licensed physician consultations. The company offers a range of services including medications for testosterone optimization, as well as treatments with clomid and anastrozole. Hone Health utilizes telemedicine and FDA-approved testing systems to monitor hormonal changes, allowing users to track their health affordably under professional medical guidance.
Shimmer
Seed Round in 2024
Shimmer provides a platform for 1:1 remote ADHD coaching. Our platform matches users to an ADHD coach who helps guide them towards identifying and meeting goals, maintaining a positive approach to change, and improving productivity while providing a source of accountability.
BetterBrand
Venture Round in 2024
BetterBrand is a food technology company focused on innovating within the refined carbohydrate sector. It aims to address the global health crisis associated with refined carbs, which significantly contributes to obesity and related health costs. BetterBrand's flagship product, The Better Bagel, reimagines traditional bagels by transforming them into a healthier option that is the net carb equivalent of two slices of banana while providing over 25 grams of plant-based protein. This product contains no added sugars and features a clean label with non-GMO verified ingredients. BetterBrand aspires to empower consumers by breaking down dietary limitations and promoting a healthier lifestyle, ultimately contributing to enhanced global productivity and well-being.
Seismic Therapeutic
Series B in 2023
Seismic Therapeutic is a biotechnology company focused on advancing immunology drug development through the integration of machine learning in the biologics discovery process. Utilizing its proprietary IMPACT™ platform, Seismic Therapeutic addresses critical challenges in the development of biologics by combining machine learning with structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies for patients more efficiently. The company is developing a pipeline of biologics specifically targeting adaptive immune system dysregulation to treat various autoimmune diseases.
Pair Team
Series A in 2023
Pair Team is dedicated to enhancing primary care infrastructure for vulnerable communities, focusing on Medicaid and Medicare patients. As the first tech-enabled care team, they support safety-net primary care systems by acting as an extension of clinical staff, delivering personalized and high-touch care experiences. Their approach addresses various barriers to healthcare access, including transportation issues, housing and food insecurity, and limitations in mobile phone access. To facilitate effective care delivery, Pair Team is developing a unique platform that ensures adherence to clinical best practices, integrates services with community-based organizations, and automates administrative tasks, allowing clinicians to concentrate more on patient interaction. The company employs a diverse team of professionals, including community health workers, registered nurses, and behavioral health clinicians, to provide comprehensive support tailored to the needs of low-income individuals, thereby promoting a holistic and patient-centered care model.
Allara Health
Series A in 2023
Allara Health is a healthcare provider specializing in virtual care for women facing complex, chronic health conditions, particularly polycystic ovary syndrome (PCOS). The company offers a comprehensive program that connects patients with medical providers and registered dietitians through virtual appointments. Allara's services include holistic care, diagnostic testing, and prescriptions, along with personalized guidance on dietary and lifestyle changes. By leveraging technology, the platform enables women to efficiently manage their health, allowing for improved tracking and treatment of their conditions.
Atropos Health
Venture Round in 2023
Atropos Health, founded in 2019 and based in Palo Alto, California, specializes in developing a digital prognostogram platform that transforms health data into usable real-world evidence. The Atropos Evidence Platform integrates electronic medical record (EMR) data to generate digital evidence tailored to individual patient outcomes. It serves a diverse clientele, including healthcare organizations, life science companies, and researchers, by enabling them to derive value from previously isolated EMR data. This cloud-based platform addresses evidence gaps from bench to bedside, enhances clinical outcomes through data-driven care, and accelerates research efforts in the medical field.
Carenostics
Seed Round in 2023
Carenostics is a health technology company focused on addressing the underdiagnosis, undertreatment, and health inequities associated with chronic diseases. Utilizing artificial intelligence and machine learning, the company develops detection models that analyze patient data gathered during routine care. These models integrate seamlessly with healthcare providers' electronic health records to identify chronic conditions that may have previously gone undiagnosed. By projecting the potential decline of patients with these conditions, Carenostics aims to prioritize them for necessary care, ultimately improving health outcomes and reducing disparities in treatment.
Remedial Health
Series A in 2023
Remedial Health is a company focused on enhancing the procurement and distribution of pharmaceuticals across Africa. It provides a platform that facilitates business-to-business access to medicines, enabling pharmacies and hospitals to order and access retail medications directly from manufacturers or distributors. This approach addresses the inefficiencies and risks associated with relying on open-air medicine markets, where healthcare providers often encounter counterfeit products. By improving the pharmacy operations and workflow management processes, Remedial Health aims to ensure that healthcare providers can more effectively stock their facilities, thereby contributing to a safer and more reliable healthcare environment.
ReflexAI
Seed Round in 2023
ReflexAI is a company that develops artificial intelligence tools aimed at enhancing the training and effectiveness of frontline teams in various sectors, including crisis services, emergency response, social services, and healthcare. Its innovative platform provides scalable AI solutions that feature advanced roleplay simulations and intelligent quality assurance, which facilitate improved outcomes in human interactions. By automating scoring and delivering real-time reporting, ReflexAI's tools enable trainees and agents to perform more efficiently while ensuring budget-conscious operations. The focus on veteran mental health further underscores the company's commitment to empowering support and contact centers, ultimately enhancing the quality and consistency of service delivery.
Alnair Therapeutics
Pre Seed Round in 2023
Alnair Therapeutics is a preclinical stage company specializing in precision oncology, dedicated to developing innovative solutions for challenging malignancies. The company has pioneered a unique drug delivery technology that harnesses the distinctive characteristics of cancer metabolism to enhance the targeting and penetration of therapeutic agents directly into cancer cells. This approach aims to improve treatment outcomes for patients suffering from difficult-to-treat cancers, addressing a significant need in the oncology field.
BetterBrand
Series A in 2023
BetterBrand is a food technology company focused on innovating within the refined carbohydrate sector. It aims to address the global health crisis associated with refined carbs, which significantly contributes to obesity and related health costs. BetterBrand's flagship product, The Better Bagel, reimagines traditional bagels by transforming them into a healthier option that is the net carb equivalent of two slices of banana while providing over 25 grams of plant-based protein. This product contains no added sugars and features a clean label with non-GMO verified ingredients. BetterBrand aspires to empower consumers by breaking down dietary limitations and promoting a healthier lifestyle, ultimately contributing to enhanced global productivity and well-being.
Every Health
Pre Seed Round in 2023
Tech-enabled healthcare solution for the underserved LGBTQIA+ community.
Movo
Venture Round in 2023
Movo is a developer of human capital management solutions focused on enhancing the mobile employee experience for frontline workers. The company's platform integrates artificial intelligence to provide supervisors with real-time insights into their personnel, improving operational efficiency. Movo's technology has been successfully implemented by large corporations with workforces of up to 80,000 employees, leading to personnel efficiency gains of up to 30%. The platform facilitates the deployment of fully credentialed professionals across various sectors, including healthcare, clean energy, manufacturing, and field engineering. By enabling supervisors to manage significantly higher task volumes, Movo aims to elevate team performance and optimize workforce management.
Aether Bio
Venture Round in 2023
Aether Bio is a technology company that focuses on re-purposing enzymes to create new compounds using machine learning. By integrating machine learning with high-throughput robotic laboratories, Aether Bio engineers enzymes rapidly and enables massively parallelized experimentation. This innovative approach generates significantly larger datasets compared to competitors, allowing researchers to manufacture complex and novel products more efficiently and at a lower cost. The company's technology aims to provide healthcare institutions with sustainable and affordable chemicals and materials essential for their operations.
Galileo
Venture Round in 2023
Galileo is a technology company based in New York, founded in 2014, specializing in healthcare solutions. The company offers a mobile application and online communication platform that enables medical professionals to provide comprehensive clinical care directly from their phones. This includes synchronous and asynchronous telecommunications technologies for connecting providers with patients. Galileo's services cater to diverse patient populations, offering high-touch, data-driven, multi-specialty longitudinal care over the phone, at home, and in various settings. The company is recognized by regional and national health plans, employers, and Fortune 500 companies as a leading solution for improving population health.
SpecCheck
Seed Round in 2023
SpecCheck is an optical platform designed to enhance the efficiency of eye care specialists. It offers an all-in-one solution that facilitates accurate prescription eyewear ordering and tracking, seamless billing, and improved communication among patients, eye doctors, and lab partners. By optimizing these processes, SpecCheck enables users to work more efficiently and reduce costly errors, ultimately increasing productivity and enhancing overall workflow within the eye care industry.
SoundMind
Seed Round in 2023
SoundMind is a mental health platform based in Los Angeles, California, that specializes in personalized music therapy to assist individuals in managing stress, anxiety, and trauma. Founded in 2020, the platform primarily targets students and marginalized communities, emphasizing the therapeutic potential of music to enhance mental wellness. SoundMind offers tailored audio and visual therapy solutions designed to improve mood and promote relaxation, enabling users to prioritize their mental health effectively. Additionally, the platform provides organizations with data-driven insights to monitor overall wellness among their members, facilitating timely interventions for users seeking moments of reset and refocus.
Previse
Seed Round in 2023
Capsulomics, LLC is a biotechnology company focused on developing and manufacturing DNA tests for the early detection of upper gastrointestinal (GI) cancers, particularly esophageal cancer and its precancerous condition, Barrett’s esophagus. Founded in 2018 and based in Halethorpe, Maryland, Capsulomics aims to address the diagnostic and prognostic uncertainties associated with GI diseases. By providing advanced diagnostic solutions, the company enables healthcare professionals to prevent, detect, and treat these conditions more effectively, ultimately enhancing patient outcomes.
Wave Life
Seed Round in 2023
Wave Life is a new kind of mental health platform that makes emotional wellbeing an achievable part of everyday life. The app's mental health coach and toolkit empower users to live each day with intention. Mental health coaching helps to build self-awareness, discover values, and cope with stress.
Healium
Seed Round in 2023
Healium is a company that specializes in providing drugless solutions for managing anxiety and sleep issues through immersive media experiences. Their technology integrates with fitness trackers and other sensors, such as smart watches or EEG meditation headbands, to create reactive video content driven by the user's brainwaves and heart rate. This approach allows users to control their bio-data displayed on the screen via hardware-agnostic sensors, offering a personalized experience that has been clinically validated in peer-reviewed journals to quickly reduce anxiety and improve mood within just four minutes.
Journey Clinical
Series A in 2023
Journey Clinical is a platform that provides services to member psychotherapy practices that are independently owned and operated, and in no way owns, directs, or controls the mental healthcare clinicians providing care.
ImmuneBridge
Venture Round in 2023
ImmuneBridge is a biotechnology company focused on developing allogeneic immunotherapies for cancer treatment. The company specializes in harnessing immune stem cells derived from cord blood, creating a novel and abundant cellular source for immunotherapy applications. ImmuneBridge aims to develop natural killer cell-based therapies targeting hematological cancers, with plans to extend their approach to solid tumors. By leveraging the unique properties of their cellular source, ImmuneBridge seeks to enhance the effectiveness and adaptability of cancer treatments, ultimately striving to discover and amplify the body’s own healing capabilities in oncology.
One Body
Seed Round in 2023
One Body is a technology company that specializes in developing automation and machine learning software tailored for the healthcare sector. Their primary focus is on enhancing the operational efficiency of physical therapy clinics through an insurance verification platform that simplifies and streamlines insurance eligibility checks. By automating the benefit verification processes, One Body helps medical providers save time and reduce costs, while also improving claim approval rates. The company’s platform integrates seamlessly with Electronic Medical Records (EMR), providing clinics and digital health startups with better access to essential data, ultimately supporting them in maximizing their profit potential and ensuring a smoother operational workflow.
Juno Medical
Series A in 2022
Juno Care is a whole-family healthcare platform that provides modern open-access care for the entire family’s day-to-day needs, including pediatrics, women’s health, adult primary care, and same-day services. The company was founded in 2020 and is based in New York, New York, United States.
Disclo
Venture Round in 2022
Disclo is a HIPAA compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. Disclo helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.
Yes Hearing
Series A in 2022
Yes Hearing is a company based in New York that specializes in providing accessible hearing solutions for seniors. Founded in 2020 by Sam Shear and Oliver Philips, the company offers a range of hearing aid devices designed to address various hearing impairments. Yes Hearing's platform facilitates access to healthcare and hearing technologies through convenient home visit therapy and remote care services, making it easier for elderly individuals to obtain and manage hearing aids from the comfort of their own homes.
Gabbi is a healthcare software company focused on empowering women to understand their health and take proactive measures in managing their well-being. Utilizing artificial intelligence and clinical research, Gabbi aims to reduce the incidence of preventable diseases and delays in diagnosis that disproportionately affect women. The company offers a unique risk model that serves as a consumer-facing platform, allowing women to assess their lifetime risk of various diseases. This platform includes personalized and interactive action plans, alongside features that foster community engagement and support. Additionally, Gabbi provides tools for breast cancer risk assessment, virtual chat options, and video appointments, facilitating connections among women with shared experiences and promoting proactive health actions.
Shimmer
Seed Round in 2022
Shimmer provides a platform for 1:1 remote ADHD coaching. Our platform matches users to an ADHD coach who helps guide them towards identifying and meeting goals, maintaining a positive approach to change, and improving productivity while providing a source of accountability.
Qnovia is a biotechnology company that specializes in aerosol science and drug delivery systems. It focuses on developing innovative inhalation-based technologies that enhance the delivery of a wide range of pharmaceuticals, addressing the limitations of traditional drug delivery methods. The company aims to improve patient outcomes by creating efficient aerosol devices and formulations that safely administer medications and nicotine. Qnovia is committed to advancing public health through responsible innovation, transparent product information, and effective oversight, positioning itself at the forefront of the medical device industry. Its platform not only optimizes the user experience but also facilitates access to new inhaled therapies, ultimately contributing to better health management for patients.
Gameto
Venture Round in 2022
Gameto is a biotechnology company focused on advancing female reproductive health through innovative therapies. Recognizing the significant lack of treatment options in this underserved area, Gameto employs cutting-edge scientific techniques to develop solutions that enhance the quality of life for women. The company utilizes cellular engineering to create a platform that produces engineered ovarian and endometrial cell lines capable of mimicking the functions of natural cells, including hormone production and response. This platform underpins a portfolio of cellular therapeutics aimed at addressing various female reproductive diseases. Gameto's first initiative, Fertilo, targets improvements in in vitro fertilization (IVF) and egg freezing processes, striving to make them shorter, safer, and more effective. Additionally, the company is developing Deovo, an organoid model of the female reproductive system, and Ameno, a cell-based therapy designed to mitigate health issues related to primary ovarian insufficiency and menopause. Through these efforts, Gameto aims to transform the landscape of female reproductive health care.
Uplift Labs
Seed Round in 2022
Uplift Labs is a company that focuses on enhancing human movement through advanced technology. Founded in 2017 and headquartered in Palo Alto, California, Uplift Labs utilizes artificial intelligence to deliver in-depth motion analysis aimed at improving athletic performance and reducing the risk of injuries. Its platform employs proprietary deep learning models and algorithms for kinematic analysis, enabling sports clubs and organizations to assess and optimize movement patterns. By providing actionable insights, Uplift Labs aims to support individuals in sports, fitness, and daily activities, ultimately promoting better movement and overall well-being.
Disclo
Pre Seed Round in 2022
Disclo is a HIPAA compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. Disclo helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.
Cartography Biosciences
Series A in 2022
Cartography Biosciences is a biotechnology company focused on developing cancer therapies through precision medicine. The company aims to revolutionize cancer immunotherapies by identifying the safest and most effective targets for treatment. Utilizing a platform-based cell therapy approach, Cartography employs single-cell analysis to discover novel CAR-T targets. This methodology empowers clients to enhance their molecular biology and computational methods, facilitating the advancement of innovative cancer immunotherapies. By prioritizing precision and safety, Cartography Biosciences is dedicated to transforming the landscape of cancer treatment.
Kindly Health is a diagnostics platform focused on sexual care and performance health, catering to both men and women. The company offers comprehensive solutions for sperm health and sexual performance in men, as well as addressing issues such as low libido, polycystic ovary syndrome (PCOS), irregular periods, and menstrual pain in women. Kindly Health enhances accessibility to its services by providing at-home diagnostic tests, such as semen analyses and PCOS assessments, along with telehealth consultations and supplements. Additionally, Kindly Health has developed an AI and computer vision tool aimed at improving the embryo selection process in fertility treatments, thereby increasing the success rate of in vitro fertilization (IVF). Through these innovations, Kindly Health strives to make fertility care and sexual health solutions more affordable and accessible for patients.
Choiz is a healthcare platform designed to provide a personalized, comprehensive healthcare experience for patients. The company focuses on delivering tailored medical treatments directly to individuals' homes, facilitating a seamless process that encompasses diagnosis, medication delivery, and ongoing care. By prioritizing accessibility, Choiz aims to connect patients with healthcare professionals and ensure they receive necessary medications on a recurring basis. This patient-centric approach is intended to make specialized care and treatment readily available to a broader audience.
STRIVE operates a platform that enhances athletic performance by collecting and analyzing muscle movement data. It employs sensors embedded in compression shorts, using techniques such as surface electromyography (sEMG) and accelerometers to gather information on muscle exertion. This data enables users to monitor muscle activity, track fatigue levels, prevent injuries, and optimize overall performance for elite athletes across various teams and leagues.
Boulder Care
Series B in 2022
Boulder Care, established in 2017 and headquartered in Portland, Oregon, specializes in telemedicine-based programs for opioid addiction treatment. The company offers comprehensive services including medication-assisted treatment with buprenorphine, peer support, patient counseling, and psychosocial services to aid recovery. Boulder Care serves patients directly, as well as healthcare providers and organizations seeking to expand access to effective opioid addiction treatment.
MindRight Health
Seed Round in 2022
MindRight Health, Inc. is a Newark, New Jersey-based company founded in 2019 that offers mental health coaching via text messaging. Its mission is to promote health equity by providing accessible and inclusive mental health care, particularly for communities of color and low-income families. MindRight partners with healthcare payers and providers to deliver culturally responsive coaching, assigning users to personal coaches who offer support year-round. This approach aims to create a continuum of care that addresses the unique needs of youth and communities that often avoid traditional clinical services due to stigma and limited access. Additionally, MindRight provides its partners with real-time data on community mental health needs, which helps in predicting and preventing mental health crises.
Torigen Pharmaceuticals
Venture Round in 2022
Torigen Pharmaceuticals is a company dedicated to advancing cancer care solutions for companion animals. Founded in 2013 by Ashley Kalinauskas and Mark Suckow, the company is based in Farmington, Connecticut. Torigen focuses on developing innovative immunotherapy treatments, including an experimental autologous cancer vaccine that activates the immune system to target specific tumor-associated antigens on cancer cells. This approach aims to enable veterinarians to detect and treat cancer in animals more effectively, reducing the reliance on invasive surgeries and chemotherapy. By leveraging existing scientific research, Torigen seeks to improve outcomes for pets diagnosed with cancer, enhancing their quality of life through novel therapeutic strategies.
OYE
Pre Seed Round in 2022
OYE is a wellness app focused on enhancing emotional well-being through mind-body practices and community engagement. The platform offers daily emotional check-ins, personalized goal setting, and mindful notifications to help users transform their emotions into creative actions. Available in both Spanish and English, OYE provides guided reflections and expressive movement practices aimed at shifting moods and improving interpersonal relationships. By fostering a supportive environment, OYE enables members of the Latino community to enhance their mental health, experience personal growth, and build connections regardless of their location.
Adni is transforming the career management landscape for healthcare workers by offering an all-in-one AI-powered super app. This innovative platform streamlines various aspects of a healthcare worker's professional life, including job matching, credential updates, networking opportunities, and ongoing education. Adni's AI agents function as career copilots, assisting healthcare professionals in saving time and money. For employers, Adni provides a unique solution that not only facilitates recruitment from its extensive professional network but also focuses on talent retention. The platform enables healthcare organizations to create a customized engagement experience for clinicians, allowing them to access necessary resources, earn rewards, and find wellness support—all in one place. By prioritizing both recruitment and retention, Adni aims to foster a satisfied and engaged workforce in the healthcare sector.
Curebase is a company that specializes in developing software for clinical trials, aimed at enhancing the efficiency of the clinical research process. Founded in 2017 and based in San Francisco, California, Curebase offers a digital clinical trial assistant that transforms how medical providers discover, activate, and manage clinical trials for patients. The platform reduces recruitment times and automates various manual processes, allowing drug companies to distribute their trials more effectively to clinics. Additionally, it provides comprehensive data access for sponsors, enabling real-time monitoring of trial progress and data management. Curebase serves a diverse clientele, including medical device, biotech, and digital health startups, with a focus on enabling virtual studies and streamlining participant eligibility, enrollment, education, and consent.
Nelly is a company that develops tools aimed at enhancing the efficiency of medical practices by simplifying patient onboarding and payment processes. It addresses the significant administrative burdens faced by healthcare professionals, which are commonly viewed as a major challenge in their daily operations. Nelly's solutions enable digital patient admission, allowing patients to complete necessary documentation and sign forms securely using their phones. This streamlined approach facilitates the collection of patient data and offers various payment options, significantly reducing the administrative workload for doctors and staff. By focusing on improving the overall experience for both patients and medical personnel, Nelly aims to create a more patient-friendly and efficient healthcare environment.
Diligent Robotics
Series B in 2022
Diligent Robotics Inc. is a company that specializes in the development and manufacturing of hospital service robots. Founded in 2017 and headquartered in Austin, Texas, the company has created Moxi, a robotic assistant designed to support clinical and nursing staff with logistical tasks in hospital settings. Moxi is equipped with advanced mobile manipulation, social intelligence, and human-guided learning capabilities, allowing it to collaborate effectively with human teams. By automating routine logistical duties, Moxi enables healthcare providers to focus more on direct patient care, thereby enhancing patient satisfaction, service quality, and safety in healthcare environments. The company also develops artificial intelligence-based software suites that allow its robots to adapt to and thrive in dynamic, semi-structured environments.
SoundMind
Pre Seed Round in 2022
SoundMind is a mental health platform based in Los Angeles, California, that specializes in personalized music therapy to assist individuals in managing stress, anxiety, and trauma. Founded in 2020, the platform primarily targets students and marginalized communities, emphasizing the therapeutic potential of music to enhance mental wellness. SoundMind offers tailored audio and visual therapy solutions designed to improve mood and promote relaxation, enabling users to prioritize their mental health effectively. Additionally, the platform provides organizations with data-driven insights to monitor overall wellness among their members, facilitating timely interventions for users seeking moments of reset and refocus.
Starling Medical
Seed Round in 2022
Starling Medical is focused on creating a remote patient monitoring platform that facilitates at-home urine diagnostics, aiming to integrate seamlessly into everyday bathroom routines. The company designs healthcare devices that utilize mass spectroscopy-based sensors for continuous monitoring and early detection of health issues through urine analysis. By tracking changes in urine composition over time, Starling Medical's technology enables timely intervention for patients and healthcare providers, potentially preventing complications and reducing the need for hospitalizations. The organization is dedicated to developing predictive technology that enhances early detection of chronic health concerns, ultimately improving patient outcomes.
One Body
Pre Seed Round in 2022
One Body is a technology company that specializes in developing automation and machine learning software tailored for the healthcare sector. Their primary focus is on enhancing the operational efficiency of physical therapy clinics through an insurance verification platform that simplifies and streamlines insurance eligibility checks. By automating the benefit verification processes, One Body helps medical providers save time and reduce costs, while also improving claim approval rates. The company’s platform integrates seamlessly with Electronic Medical Records (EMR), providing clinics and digital health startups with better access to essential data, ultimately supporting them in maximizing their profit potential and ensuring a smoother operational workflow.
Minded is an online psychiatry practice focused on providing mental health care specifically for women. It operates a consumer telehealth platform that simplifies the process of obtaining and managing prescriptions for anxiety and depression. Through its platform, Minded enables patients to easily renew and refill their medications online, which are then delivered directly to their homes. This approach alleviates the challenges associated with scheduling appointments and managing medication supplies, ensuring that women can access the mental health support they need with greater convenience and efficiency.
Wavely Diagnostics
Seed Round in 2022
Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care.
Uplift Labs
Seed Round in 2022
Uplift Labs is a company that focuses on enhancing human movement through advanced technology. Founded in 2017 and headquartered in Palo Alto, California, Uplift Labs utilizes artificial intelligence to deliver in-depth motion analysis aimed at improving athletic performance and reducing the risk of injuries. Its platform employs proprietary deep learning models and algorithms for kinematic analysis, enabling sports clubs and organizations to assess and optimize movement patterns. By providing actionable insights, Uplift Labs aims to support individuals in sports, fitness, and daily activities, ultimately promoting better movement and overall well-being.
Skippet
Seed Round in 2022
Skippet is a company that specializes in creating custom digital solutions through natural language processing. Users can describe their problems in plain English, and Skippet's proprietary architecture translates this input into functional applications or workflows tailored to the user’s existing systems and integrations. This approach allows individuals and organizations to address specific needs without requiring coding expertise. The company's technology leverages state-of-the-art language models to deliver fit-for-purpose solutions efficiently.
AmorSui
Seed Round in 2022
AmorSui is a modern protective apparel company that specializes in the design and innovation of medical gowns and lab jackets for healthcare professionals. Founded in 2020 by Beau Wangtrakuldee, PhD, the company emerged from a personal experience that highlighted the need for better protective gear. AmorSui's products are characterized by their antimicrobial properties, static resistance, and protection against bodily fluids, while being reusable and recyclable. Committed to sustainability, the company ensures that all its apparel is made and sourced entirely in the USA. In addition to its protective garments, AmorSui offers a management platform that utilizes data analytics to monitor the lifecycle of its products, enabling healthcare facilities to reduce waste and costs while ensuring employee safety.
Limbix is a prescription digital therapeutic company focused on developing innovative mental health treatments specifically for adolescents. The company offers a digital therapeutics platform designed to address the mental health challenges faced by young people, including depression and anxiety. Limbix's first product, SparkRx, enables licensed healthcare professionals to prescribe evidence-based, therapeutic interventions to improve the mental well-being of their patients. The diverse team at Limbix, consisting of clinicians, product designers, researchers, and engineers, combines clinical expertise with technological innovation to create effective digital solutions for adolescent mental health.
Sonic Incytes Medical
Series A in 2021
Sonic Incytes Medical Corp is a medical device company based in Vancouver, Canada, focused on developing handheld ultrasound solutions for the assessment and monitoring of chronic liver diseases. Incorporated in 2012, the company specializes in quantitative ultrasound technology that supports point-of-care diagnostics and procedure guidance. Its portable devices provide a non-invasive method for diagnosing liver diseases, particularly in quantifying fatty liver disease, thereby enhancing the standard of care provided by medical practitioners. The company's mission is to facilitate routine assessment and management of liver health with reliable diagnostic accuracy.
Suki is a technology company that specializes in AI-driven voice solutions aimed at improving efficiency in healthcare documentation. Its flagship product, Suki Assistant, allows physicians to complete administrative tasks more quickly, alleviating the administrative burden on clinicians. The company utilizes advanced natural language processing and machine learning technologies to deliver a proprietary voice platform that offers high accuracy and a seamless voice experience. Through its innovative solutions, Suki seeks to transform the healthcare technology landscape into an invisible and supportive tool, enhancing the overall workflow for healthcare professionals.
CareAlign
Seed Round in 2021
CareAlign is a developer of a real-time data system that enhances the management and coordination of clinical care for clinicians. The company offers an intuitive, patient-centric task management tool that allows healthcare professionals to assign tasks, set deadlines, and categorize them based on urgency. By aggregating data from multiple sources, CareAlign provides a comprehensive and clinically intuitive display of patients' clinical status, facilitating better understanding and decision-making in patient care. This system aims to streamline workflows and improve communication among clinicians, ultimately enhancing the quality of care delivered to patients.
OxiWear
Pre Seed Round in 2021
OxiWear develops innovative ear-wearable devices specifically designed for continuous oxygen monitoring and emergency alerting, targeting patients prone to silent hypoxia due to conditions such as pulmonary hypertension, high-altitude environments, high-intensity cardio activities, and COVID-19. The company's patented pulse oximeter offers a novel approach to monitoring oxygen levels, facilitating use in both clinical and consumer settings. By providing real-time data and alerts, OxiWear's technology enhances patient safety and peace of mind, ensuring timely medical assistance when needed.
Valera Health
Venture Round in 2021
Valera Health, founded in 2015, operates a behavioral healthcare platform that integrates digital technology and data science with personalized clinical services. The company focuses on delivering comprehensive mental health care to individuals experiencing a range of conditions, from mild issues like depression to more severe disorders such as schizophrenia. By combining therapy and medication with advanced technology, Valera Health aims to provide efficient access to mental health services, particularly for hard-to-reach populations. This approach not only enhances patient outcomes but also facilitates continuous connectivity between patients and their care teams, thereby redefining the standards of high-performing mental healthcare.
Ruth Health
Seed Round in 2021
Ruth Health is a telehealth facility specializing in women's and prenatal care, aiming to empower parents throughout their pregnancy journey and beyond. The company offers a comprehensive platform that provides medical services and consultations to address various women's health issues, including postpartum care, painful sex, and unwanted urination. Ruth Health enhances access to childbirth care by providing at-home ultrasound services and online consultations with healthcare professionals. By prioritizing evidence-based expertise, the company strives to make childbirth care more affordable, accessible, and enjoyable, allowing women to take control of their health as they navigate family planning and new parenthood.
Aether Bio
Seed Round in 2021
Aether Bio is a technology company that focuses on re-purposing enzymes to create new compounds using machine learning. By integrating machine learning with high-throughput robotic laboratories, Aether Bio engineers enzymes rapidly and enables massively parallelized experimentation. This innovative approach generates significantly larger datasets compared to competitors, allowing researchers to manufacture complex and novel products more efficiently and at a lower cost. The company's technology aims to provide healthcare institutions with sustainable and affordable chemicals and materials essential for their operations.
Zeit Medical
Seed Round in 2021
Zeit Medical is a company focused on advancing the treatment of neurological injuries through innovative technology. Founded in 2019 by Urs Naber and Orestis Vardoulis, the company has developed a specialized headband that continuously monitors the electrical activity of the brain. This device integrates smoothly with existing electroencephalogram (EEG) systems and automates the pre-screening process, facilitating the annotation of extensive datasets. By identifying signature patterns in EEG readings, Zeit Medical enables physicians to diagnose and treat neurological conditions with greater precision, particularly in detecting the onset of strokes.
BIOMILQ is a women-owned start-up based in Durham, North Carolina, founded in 2020. The company specializes in producing nutritionally equivalent breastmilk using cultured human mammary cells. By leveraging a unique biomanufacturing platform, BIOMILQ aims to create bioauthentic human milk ingredients that support early-life nutrition. Its products are designed to provide a sustainable and nutritious alternative for mothers and caregivers, promoting immune, gut, and neurological development in infants. Through its patented technology, BIOMILQ seeks to empower families with options that mirror the benefits of natural breastmilk, enhancing infant health and nutrition.
Options MD
Pre Seed Round in 2021
Options MD is a telemedicine platform focused on delivering personalized care for individuals experiencing severe and treatment-resistant mental illnesses. The company operates a treatment-matching system that utilizes artificial intelligence to pair patients with tailored treatment options. By connecting users with psychiatric experts, Options MD aims to streamline the process of finding effective depression care, ensuring that patients receive the appropriate medical attention more efficiently. Through its innovative approach, Options MD addresses the challenges faced by those seeking specialized support for their mental health conditions.
Sonavi Labs
Seed Round in 2021
Sonavi Labs, Inc. is a medical device and software company based in Baltimore, Maryland, founded in 2017. The company specializes in developing advanced technologies that analyze body sounds to aid in the diagnosis of respiratory diseases. By utilizing artificial intelligence, Sonavi Labs creates innovative products that enhance the capabilities of healthcare providers and improve patient experiences. Its devices are designed to detect and manage respiratory conditions by listening to bodily sounds and identifying abnormalities, thereby enabling healthcare professionals to monitor, diagnose, and potentially predict diseases effectively. Through its focus on modern medical solutions, Sonavi Labs aims to transform the landscape of respiratory health monitoring.
Eleos Health
Seed Round in 2021
Eleos Health is a technology company that specializes in artificial intelligence-driven solutions for the behavioral health sector. It has developed a voice technology platform designed to enhance clinicians' decision-making by providing real-time insights during mental health sessions. This AI-powered system operates in the background, analyzing voice interactions and other data parameters to generate valuable information about patients. By leveraging this technology, Eleos Health aims to facilitate personalized care, ensuring that mental health professionals can deliver timely and cost-effective support tailored to individual needs.
Movo
Funding Round in 2021
Movo is a developer of human capital management solutions focused on enhancing the mobile employee experience for frontline workers. The company's platform integrates artificial intelligence to provide supervisors with real-time insights into their personnel, improving operational efficiency. Movo's technology has been successfully implemented by large corporations with workforces of up to 80,000 employees, leading to personnel efficiency gains of up to 30%. The platform facilitates the deployment of fully credentialed professionals across various sectors, including healthcare, clean energy, manufacturing, and field engineering. By enabling supervisors to manage significantly higher task volumes, Movo aims to elevate team performance and optimize workforce management.
Kenshō Health
Seed Round in 2021
Kenshō Health is a Los Angeles-based health company that operates online, emphasizing a whole-person approach that integrates mind, body, and spirit. Founded by experienced entrepreneurs Krista Berlincourt and Danny Steiner, Kenshō combines scientific research with personalization technology to simplify holistic health care. The company offers an on-demand wellness service booking platform that connects users with verified wellness providers across various specialties, including acupuncture, massage, yoga, naturopathy, and meditation. By enabling individuals to easily find and book wellness professionals, Kenshō aims to support a balanced and healthy lifestyle without the need for in-person visits.
Woebot Health
Series B in 2021
Woebot Health is a digital mental healthcare provider that offers a platform designed to deliver personalized support and guidance. Utilizing advanced artificial intelligence and natural language processing, Woebot Health incorporates clinically proven therapeutic techniques into its services. The centerpiece of its offering is Woebot, an engaging relational agent that facilitates continuous, empathic, and user-friendly interactions. This innovative approach allows individuals and organizations to access effective mental health support seamlessly, fitting into daily life and providing help whenever needed. Woebot Health aims to enhance mental well-being through scalable digital tools, making mental health resources more accessible to a broad audience.
Crescent Health
Pre Seed Round in 2021
Crescent Health is working to make sleep health accessible to all. It hastens the development of individual health, beginning with sleep. They are employed by meet sleep coach. Connecting a sleep monitor to an app get monthly customized sleep plans, track sleep health, and find the ideal schedule.
Ruth Health
Pre Seed Round in 2021
Ruth Health is a telehealth facility specializing in women's and prenatal care, aiming to empower parents throughout their pregnancy journey and beyond. The company offers a comprehensive platform that provides medical services and consultations to address various women's health issues, including postpartum care, painful sex, and unwanted urination. Ruth Health enhances access to childbirth care by providing at-home ultrasound services and online consultations with healthcare professionals. By prioritizing evidence-based expertise, the company strives to make childbirth care more affordable, accessible, and enjoyable, allowing women to take control of their health as they navigate family planning and new parenthood.
Brightline
Series B in 2021
Brightline, Inc. is a pediatric behavioral health care provider that focuses on supporting children and their families through innovative technology and integrated care. Established in 2019 and headquartered in Palo Alto, California, Brightline offers a range of services including behavioral therapy, psychiatry, medication support, speech-language therapy, and occupational therapy. The company emphasizes virtual behavioral health services and a collaborative care team to address the diverse needs of children at various developmental stages. Originally named Emilio Health, Inc., the company rebranded to Brightline in May 2020, reflecting its commitment to delivering accessible and comprehensive behavioral health solutions.
Protenus, Inc. is a healthcare compliance analytics company based in Baltimore, Maryland, which was founded in 2014. The company specializes in an AI-driven platform designed to audit access to patient records across health systems in the United States. Protenus' technology identifies risks such as inappropriate access to patient data and the misuse of controlled substances by healthcare staff. By automating the detection of policy violations and other anomalous behaviors, the platform supports healthcare organizations in protecting patient privacy and reducing operational risks. Protenus is recognized for its innovation and commitment to fostering safe patient outcomes while enhancing the reputation of healthcare providers. The company has received accolades such as being named one of America's Best Startup Employers by Forbes and recognized as a Great Place to Work.
Silver Bills
Seed Round in 2021
SilverBills specializes in bill-paying technology aimed at alleviating the burden of managing bills for seniors. The company offers a service that receives clients' bills electronically, carefully reviews them, and processes payments using secure technology. This system is designed to simplify daily financial management, allowing elderly Americans and their families to maintain their independence and live comfortably in their homes. SilverBills charges a straightforward, flat monthly fee for its services, thereby reducing the stress and anxiety often associated with bill payments.
Ever/Body
Series B in 2021
Ever/Body is a New York-based provider of dermatology and cosmetic treatments, focusing on demystifying the field of cosmetic dermatology. The company offers a range of services, including injectable treatments, high-tech facials, and non-surgical body treatments. These medically-tested procedures are designed to deliver optimal results, such as reducing wrinkles and enhancing overall appearance, allowing clients to achieve a more youthful and rejuvenated look. By prioritizing client preferences, Ever/Body aims to make beauty and cosmetic care accessible and effective.
Gilgamesh Pharmaceuticals
Series A in 2021
Gilgamesh Pharmaceuticals, Inc. is a preclinical biotechnology company based in New York, focused on developing innovative psychotropic drugs to address mental health issues. Founded in 2019, the company specializes in creating novel compounds that enhance the benefits of traditional psychedelics, improving parameters such as safety, tolerability, duration, and efficacy. Gilgamesh targets a range of neuropsychiatric conditions, including depression, anxiety, substance use disorders, and stress-related issues. With the growing global mental health crisis, the company aims to accelerate the development of new treatments that meet the urgent need for effective solutions in mental health care, leveraging its expertise in medicinal chemistry and drug development.
CareRev is an innovative healthcare staffing marketplace that connects healthcare facilities directly with per diem medical staff, eliminating intermediaries such as vendors and agencies. This online platform allows hospitals and outpatient facilities to efficiently fill empty shifts, enhancing staffing flexibility while reducing costs. By facilitating direct communication between healthcare providers and clinical professionals, CareRev enables healthcare facilities to maintain adequate nurse-to-patient ratios and improve overall patient care quality. The platform empowers healthcare professionals to choose when and where they work, fostering a more adaptable workforce in the healthcare sector.
American Gene Technologies
Venture Round in 2021
American Gene Technologies International Inc., established in 2007 and based in Rockville, Maryland, is a biotechnology company specializing in gene and cell therapeutics. It develops a lentiviral platform for diverse applications, including large and orphan indications, infectious diseases, immuno-oncology, and monogenic disorders. The company's portfolio includes a lead candidate for an HIV functional cure, a novel immuno-oncology approach for stimulating gamma-delta T cells, and a synthetic gene for treating Phenylketonuria (PKU). AGT aims to create long-term value for patients, society, investors, and donors by developing and testing cutting-edge gene therapies to cure some of humanity's worst diseases.
Territory Foods
Series B in 2021
Territory Foods is a meal delivery service that specializes in chef-prepared, nutritionist-approved meals tailored to meet various dietary preferences and regional tastes. Founded in 2011 and headquartered in Arlington, VA, the company offers a rotating menu of freshly made artisan meals that are responsibly sourced and free of refined sugars, gluten, and dairy. Meals are designed by in-house culinary professionals and nutrition experts, with an emphasis on customization to accommodate dietary templates such as Vegan, Vegetarian, Whole30, and Keto. Territory Foods utilizes a proprietary algorithm to provide personalized menu options at scale, allowing health-conscious consumers to enjoy convenient, ready-to-eat meals delivered to their doorstep.
Cleo Labs, Inc. is a family support platform that offers pregnancy consultancy and parenthood guidance services to working parents. The company provides a range of consultation services, including lactation support, birth preparation, child wellness, and sleep consulting, as well as career coaching and immediate post-birth assistance. Cleo's mobile application connects families with certified care practitioners, facilitating their journey from fertility through parenting children up to age five. By partnering with employers, Cleo aims to enhance workplace culture, improve employee retention, and foster diverse and inclusive environments. The company operates globally, serving clients in over 50 countries and has collaborated with notable organizations such as eBay and LinkedIn. Founded in 2016 and headquartered in San Francisco, Cleo was previously known as Instacare Group, Inc. before rebranding in 2018.
BrightInsight
Series C in 2021
BrightInsight operates a digital health platform tailored for biopharma and medtech companies. Founded in 2017 and headquartered in San Jose, California, the company provides an Internet of Things (IoT) solution designed to support the development, scaling, and maintenance of regulated digital health products and services. The BrightInsight platform captures, transmits, and analyzes data from various sources, including medical devices, combination products, applications, and digital therapeutics, all while adhering to security, privacy, and regulatory standards. This integrated approach enables clients to enhance patient adherence and engagement, accelerate market entry, and reduce implementation costs across diverse products and global markets.
Breathwrk
Seed Round in 2021
Breathwrk, Inc. is a company based in Venice, California, that specializes in developing a mobile application focused on guided breathing exercises. Founded in 2019, the Breathwrk app offers science-backed techniques designed to enhance mental and physical wellness. Users can access a variety of easy-to-follow exercises aimed at alleviating anxiety, promoting better sleep, increasing energy levels, and improving mood. The application also addresses issues related to athletic performance, stress management, and mental clarity, making it a versatile tool for individuals seeking to improve their overall well-being. Through its innovative approach to breath work, Breathwrk empowers users to take control of their mental and physical health.
ELANZA Wellness
Pre Seed Round in 2021
ELANZA Wellness is a virtual chronic care platform specifically designed for individuals with endometriosis and other chronic reproductive health conditions. The company focuses on providing a comprehensive care ecosystem that combines access to medical specialists, evidence-based therapies, and personalized treatment plans. By emphasizing a whole-person approach, ELANZA Wellness aims to ensure that patients feel heard and understood throughout their healthcare journey. The platform offers tailored therapeutic programs developed by multi-disciplinary teams, empowering users to manage their symptoms effectively and make informed lifestyle changes. This commitment to holistic care helps individuals take control of their health and well-being, ultimately leading to more symptom-free days and improved quality of life.
Harmonize
Series A in 2021
Harmonize is a company that specializes in a remote care platform aimed at enhancing the management of high-risk patients, particularly those who may struggle with technology and have multiple health conditions. Founded in 2019 and headquartered in San Mateo, California, Harmonize's platform streamlines technology implementation and clinical triage, enabling healthcare organizations to provide effective remote care. The interface is designed to accommodate both high-tech and high-touch inputs, facilitating improved patient engagement and adherence rates. By guiding healthcare staff through triage and intervention processes at scale, Harmonize significantly reduces operational overhead while promoting better patient outcomes and lowering healthcare costs.
Feel Therapeutics
Seed Round in 2021
Feel Therapeutics is a digital precision medicine company focused on mental health. It develops physiological and digital biomarkers, along with therapeutics, to enhance the diagnosis, management, and care of mental health conditions. The company's flagship product is a data monitoring device, which is a wristband equipped with five embedded sensors that collect biometric data. This data is analyzed using advanced computer science techniques to create digital biomarkers. Feel Therapeutics aims to provide objective data and passive monitoring to help users improve their mental well-being and cultivate lasting positive emotional habits through its proprietary algorithms and medical-grade wearables.
Fuzzy, established in 2016 and headquartered in San Francisco, is a pet healthcare startup offering subscription-based services. It aims to make pet care accessible, affordable, and convenient. Through its mobile application, Fuzzy provides 24/7 veterinary consultations via chat and video. Additionally, it offers home delivery of pet essentials such as medications, supplements, and food for dogs and cats. The company's mission is to cater to the personalized needs of pets, allowing owners to manage their pets' health from home. Notable investors include Precursor Ventures, Eniac Ventures, and Matrix Partners.
Kenshō Health
Venture Round in 2021
Kenshō Health is a Los Angeles-based health company that operates online, emphasizing a whole-person approach that integrates mind, body, and spirit. Founded by experienced entrepreneurs Krista Berlincourt and Danny Steiner, Kenshō combines scientific research with personalization technology to simplify holistic health care. The company offers an on-demand wellness service booking platform that connects users with verified wellness providers across various specialties, including acupuncture, massage, yoga, naturopathy, and meditation. By enabling individuals to easily find and book wellness professionals, Kenshō aims to support a balanced and healthy lifestyle without the need for in-person visits.
Plume Clinic
Series A in 2021
Plume is a health tech company for the transgender community. The company focuses on radically increasing access to care, medication, and products for the trans community, supporting a bold, authentic and healthy lifestyle. Its vision is to make gender-affirming care available to anyone until it transforms healthcare for every trans life.
Kit.com
Seed Round in 2021
Kit.com is a company that specializes in at-home medical testing solutions, providing health testing kits designed to facilitate preventative health assessments across various industries. By enabling insurers and telehealth companies to offer convenient testing options, Kit.com aims to enhance patient access to essential health services from the comfort of their homes. The company's offerings include comprehensive testing services that serve as safe and reliable alternatives to traditional doctor and laboratory visits. Additionally, Kit.com is involved in supplying a diverse range of products, including electronics and sporting goods, available for online shopping, thereby addressing customer inquiries through multiple channels such as phone, email, and online applications.